today's Pick
US frees up another experimental Ebola drug
Publish Date: Aug 08, 2014
newvision
  • mail
  • img

WASHINGTON - US regulators loosened restrictions on a new experimental drug for treating Ebola, which may allow it to be tried on infected patients in West Africa, the company said yesterday.

The Canada-based company, Tekmira, said the US Food and Drug Administration changed the classification of its drug TKM-Ebola from full clinical hold to partial hold.

"This action enables the potential use of TKM-Ebola in individuals infected with Ebola virus," said a company statement.

Tests on monkeys have shown the drug provided 100 percent protection from an otherwise lethal dose of Ebola, the company said.

West Africa is experiencing the largest outbreak of Ebola in history. The virus has killed 932 people of more than 1,700 infected, and the disease continues to spread.

"This current outbreak underscores the critical need for effective therapeutic agents to treat the Ebola virus," said Mark Murray, CEO and president of Tekmira Pharmaceuticals.

"We recognize the heightened urgency of this situation, and are carefully evaluating options for use of our investigational drug within accepted clinical and regulatory protocols."

TKM-Ebola is being developed under a $140 million contract with the US Department of Defense's Medical Countermeasure Systems BioDefense Therapeutics Joint Product Management Office.

The drug, described as an anti-Ebola virus RNAi therapeutic, is designed to be given in multiple doses, which is not always practical in a mass outbreak.

However, there are no drugs on the market to treat Ebola and no vaccines against it.

The rapidly growing outbreak in West Africa has sped up the process of getting experimental therapies to market, though experts say it may be months before production can be scaled up and the drugs delivered to those in need.

The two American missionaries who were evacuated from Liberia in recent days were given a different experimental serum known as ZMapp.

Both Kent Brantly and Nancy Writebol are improving, but health authorities say it is too early to tell if the drug had anything to do with that.

Related Stories

Ebola discoverer says would sit next to victim

Too early to send experimental Ebola drug to Africa - Obama

 

The statements, comments, or opinions expressed through the use of New Vision Online are those of their respective authors, who are solely responsible for them, and do not necessarily represent the views held by the staff and management of New Vision Online.

New Vision Online reserves the right to moderate, publish or delete a post without warning or consultation with the author.Find out why we moderate comments. For any questions please contact digital@newvision.co.ug

  • mail
  • img
blog comments powered by Disqus
Also In This Section
Grief, tears at dead graduate
SHE only graduated in January with a bachelor’s degree in Economics from Makerere and had just gotten a job...
Kenya torches 15-tonne ivory stockpile
KENYAN President Uhuru Kenyatta set fire to a giant pile of 15 tonnes of elephant ivory...
Prosecutors seek 10yr jail term for Simone Gbagbo
PROSECUTERS in Ivory Coast have asked judges to sentence former first lady Simone Gbagbo to a ten-year prison term...
Phone and Internet firms are rolling out cheaper handsets and may turn to hot-air balloons to boost network coverage in developing countries, where sales of smartphones are booming....
Penis size: researchers provide the long and short of it
The enduring question now has a scientific answer: 13.12 centimetres (5.16 inches) in length when erect, and 11.66 cm around, according to an analysis of more than 15,000 appendages around the world....
Gambia shuts down
The Gambia has banned gambling, it announced on Monday, denouncing the industry as "exploitative" and saying the government acted to prevent its youth from becoming a generation of addicts....
Is KCCA doing enough to curb poor hygeine?
Yes
No
Can't Say
follow us
subscribe to our news letter